Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661267 · ClinicalTrials.gov registry record · NA
Randomized Trial of Regenexx Stem Cell Support Formula
A NA study, sponsored by Regenexx.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04661267 is a NA study that has completed, run by Regenexx. The registered enrollment target is 80 participants.
The verdict
NCT04661267, a NA study, has completed, sponsored by Regenexx.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Regenexx, LLC developed a nutritional supplement formula containing many components related to supporting healthy joints This oral, liquid supplement is intended to help improve joint and cartilage health while also increasing their joint function. The goal of this study is to measure changes in joint health and function for patients with knee OA taking this supplement for 2 months.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Stem Cell Support Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04661267
The ClinicalTrials.gov registry entry for NCT04661267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04661267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04661267 about?
NCT04661267 is a clinical study titled "Randomized Trial of Regenexx Stem Cell Support Formula". Regenexx, LLC developed a nutritional supplement formula containing many components related to supporting healthy joints This oral, liquid supplement is intended to help improve joint and cartilage health while also increasing their joint function. The goal of this study is to measure changes in joi...
What is the current status of trial NCT04661267?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2021-02-03. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT04661267?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Stem Cell Support Formula (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04661267?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.